White Papers

Our white papers seek to promote understanding, encourage fresh thinking, and give readers a deep dive into a variety of trending topics around innovative drug development and manufacturing. Each is a natural extension of our dedication to match your needs and interests with our expertise and capabilities.

08.17.2022

How CDMOs Can Support Nanoparticles for Gene Therapy, Immuno-Oncology and Vaccines

Nanoparticles have experienced increasing demand in recent years in biopharmaceutical formulations, owing to their utility for...

03.14.2022

Streamlining Your Process Development Journey to GMP Manufacturing

Many CDMOs specialize in certain parts of the drug development lifecycle. Meanwhile, integrated turn-key offerings that support...

11.19.2021

Finding the Right CDMO Partner for Tech Transfer

Regardless of where a drug candidate is in the development pipeline, performing a technology transfer (tech transfer) presents...

08.30.2021

Utilizing Expertise & Experience for Successful Downstream Processing

Successful downstream processing provides isolation of the molecule of interest from extraneous constituents before formulation,...

08.19.2021

Benefits of RABS and Isolator Technology in a Changing Regulatory Landscape

Mitigating risk is a key consideration for biopharmaceutical companies when planning their clinical trial material and/or drug...